Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-02

Clinical Trial Update: ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation [NA]

View source ↗

Summary

A multicenter interventional trial evaluating an early repigmentation approach to halt vitiligo progression has completed (NCT04843059).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Vitiligo | NA | Status: COMPLETED